Keisuke Yamamura - AILBRY - Article Search

Results for 'Keisuke Yamamura' :

Abstract B89: Expression of DNA damage repair enzymes determine the efficacy of a novel dUTPase inhibitor, TAS-114.

Publication Year: 2013

DOI: https://doi.org/10.1158/1535-7163.targ-13-b89

Abstract:

Authors:
- Sayaka Tsukioka
- Wakako Yano
- Tatsushi Yokogawa
- Takeshi Wakasa
- Akio Fujioka
- Keisuke Yamamura
- Satoko Itoh
- Masayoshi Fukuoka
- Kenichi Matsuo
- Keiichi Noguchi
- Teruhiro Utsugi
Abstract B88: TAS-114, a dUTPase inhibitor, in combination with pemetrexed is a novel strategy for the treatment of NSCLC.

Publication Year: 2013

DOI: https://doi.org/10.1158/1535-7163.targ-13-b88

Abstract:

Authors:
- Wakako Yano
- Sayaka Tsukioka
- Tatsushi Yokogawa
- Satoko Ito
- Keiji Ishida
- Keisuke Yamamura
- Akio Fujioka
- Masayoshi Fukuoka
- Kenichi Matsuo
- Keiichi Noguchi
- Teruhiro Utsugi
Catching Up in Education in the Economic Catch‐up of Japan with the United States, 1890–1990

Publication Year: 2002

DOI: https://doi.org/10.1086/342762

Abstract:

Authors:
- Yoshihisa Godo
- Yūjirō Hayami
Deglutition.

Publication Year: 1982

DOI: https://doi.org/10.1152/physrev.1982.62.1.129

Abstract:

Authors:
- Arthur J. Miller
Correction to “Stability of the Liquid State of Imidazolium-Based Ionic Liquids under High Pressure at Room Temperature”

Publication Year: 2021

DOI: https://doi.org/10.1021/acs.jpcb.1c06814

Abstract:

Authors:
- Yukihiro Yoshimura
- Machiko Shigemi
- Mayumi Takaku
- Misaho Yamamura
- Takahiro Takekiyo
- Hiroshi Abe
- Nozomu Hamaya
- Daisuke Wakabayashi
- Keisuke Nishida
- Nobumasa Funamori
- Tomoko Sato
- Takumi Kikegawa
Immunogenicity of Induced Pluripotent Stem Cells

Publication Year: 2011

DOI: https://doi.org/10.1161/res.0b013e318232e187

Abstract:

Authors:
- Keisuke Okita
- Naoki Nagata
- Shinya Yamanaka
Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus

Publication Year: 2016

DOI: https://doi.org/10.4049/jimmunol.1502367

Abstract:

Authors:
- Naomoto Harada
- Satoshi Fukaya
- Hiroshi Wada
- Risa Goto
- Toshihiro Osada
- Akira Gomori
- Koichi Ikizawa
- Motomu Sakuragi
- N. ODA
Tribute to Our Reviewers

Publication Year: 2021

DOI: https://doi.org/10.1111/den.14126

Abstract:

Authors:
- Takayuki Matsumoto
The role of vole populations in prevalence of the parasite (Echinococcus multilocularis) in foxes

Publication Year: 1998

DOI: https://doi.org/10.1007/bf02765225

Abstract:

Authors:
- Takashi Saitoh
- Kenichi Takahashi
Evolution of Synthetic Strategies for Highly Functionalized Natural Products: A Successful Route to Bryostatin 3

Publication Year: 2004

DOI: https://doi.org/10.1246/bcsj.77.875

Abstract:

Authors:
- Ken Ohmori
Abstract B86: Potent antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, on both cetuximab-sensitive KRAS wild-type and cetuximab-resistant KRAS mutated colorectal cancer cells via trifluorothymidine incorporation into DNA.

Publication Year: 2013

DOI: https://doi.org/10.1158/1535-7163.targ-13-b86

Abstract:

Authors:
- Nozomu Tanaka
- Yukari Yamada
- Akio Fujioka
- Keisuke Yamamura
- Satoko Ito
- Kenichi Matsuo
- Teruhiro Utsugi
The Role of Myocardin-Related Transcription Factor-Serum Response Factor Signaling in Peritoneal Mesothelial Cells

Publication Year: 2023

DOI: https://doi.org/10.1681/asn.20233411s1918c

Abstract:

Authors:
- Daichi Kaikoi
- Norihiko Sakai
- Yuta Yamamura
- Keisuke Sako
- Keisuke Horikoshi
- Takahiro Yuasa
- Taichiro Minami
- Shiori Nakagawa
- Megumi Oshima
- Shinji Kitajima
- Tadashi Toyama
- Akinori Hara
- Miho Shimizu
- Yasunori Iwata
- Takashi Wada
Abstract B87: Preclinical investigation of the potentiation in antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, in combination with irinotecan (CPT-11) in colorectal cancer.

Publication Year: 2013

DOI: https://doi.org/10.1158/1535-7163.targ-13-b87

Abstract:

Authors:
- Keiji Ishida
- Nozomu Tanaka
- Sayaka Tsukioka
- Kokoro Eshima
- Akio Fujioka
- Keisuke Yamamura
- Satoko Ito
- Kenichi Matsuo
- Teruhiro Utsugi
ULVAC research and development of Cat-CVD applications

Publication Year: 2007

DOI: https://doi.org/10.1016/j.tsf.2007.06.209

Abstract:

Authors:
- Shin Asari
- Tetsushi Fujinaga
- Makiko Takagi
- Masanori Hashimoto
- Kazuya Saito
- Masamichi Harada
- M. Ishikawa
A Case of Rare Multiple Gastric Cancer with Duplicate Histological Types

Publication Year: 2013

DOI: https://doi.org/10.4030/jjcs.38.795

Abstract:

Authors:
- Yoshiyuki Yamamura
- Jun Muto
- Aki Kuroda
- Junkichi Koinuma
- Tatsuya Yoshioka
- Takehiro Noji
- Katsuhiko Murakawa
- Setsuyuki Otake
- Koichi Ono
- Keisuke Kikuchi

Found 65 results in 0.101 seconds

What is Boolean Searches

Including any of the words AND, OR, or NOT in any of your searches will enable boolean search. Those words must be UPPERCASE. You can use this in all searches, including using the search parameter, and using search filters.

This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks. Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and stop-word removal (be sure to use double quotation marks — "). Using parentheses will specify order of operations for the boolean operators. Words that are not separated by one of the boolean operators will be interpreted as AND.

Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard and fuzzy searches using *, ? or ~ are not allowed; these characters will be removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as described above, including stemming and removal of stop words.

Example Search

Search for works that mention "elmo" and "sesame street", but not the words "cookie" or "monster":

AILBRY - Article Search

Results for 'Keisuke Yamamura' :

Abstract B89: Expression of DNA damage repair enzymes determine the efficacy of a novel dUTPase inhibitor, TAS-114.

Abstract B88: TAS-114, a dUTPase inhibitor, in combination with pemetrexed is a novel strategy for the treatment of NSCLC.

Catching Up in Education in the Economic Catch‐up of Japan with the United States, 1890–1990

Deglutition.

Correction to “Stability of the Liquid State of Imidazolium-Based Ionic Liquids under High Pressure at Room Temperature”

Immunogenicity of Induced Pluripotent Stem Cells

Generation of a Novel HLA Class I Transgenic Mouse Model Carrying a Knock-in Mutation at the β2-Microglobulin Locus

Tribute to Our Reviewers

The role of vole populations in prevalence of the parasite (<i>Echinococcus multilocularis</i>) in foxes

Evolution of Synthetic Strategies for Highly Functionalized Natural Products: A Successful Route to Bryostatin 3

Abstract B86: Potent antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, on both cetuximab-sensitive <i>KRAS</i> wild-type and cetuximab-resistant <i>KRAS</i> mutated colorectal cancer cells via trifluorothymidine incorporation into DNA.

The Role of Myocardin-Related Transcription Factor-Serum Response Factor Signaling in Peritoneal Mesothelial Cells

Abstract B87: Preclinical investigation of the potentiation in antitumor effect of TAS-102, a novel oral anti-neoplastic nucleoside agent, in combination with irinotecan (CPT-11) in colorectal cancer.

ULVAC research and development of Cat-CVD applications

A Case of Rare Multiple Gastric Cancer with Duplicate Histological Types

What is Boolean Searches

Example Search